[go: up one dir, main page]

WO2010030811A3 - Antibiotiques de type β-lactame à base de carbacéphème - Google Patents

Antibiotiques de type β-lactame à base de carbacéphème Download PDF

Info

Publication number
WO2010030811A3
WO2010030811A3 PCT/US2009/056555 US2009056555W WO2010030811A3 WO 2010030811 A3 WO2010030811 A3 WO 2010030811A3 US 2009056555 W US2009056555 W US 2009056555W WO 2010030811 A3 WO2010030811 A3 WO 2010030811A3
Authority
WO
WIPO (PCT)
Prior art keywords
carbacephem
lactam antibiotics
methicillin
prodrugs
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/056555
Other languages
English (en)
Other versions
WO2010030811A2 (fr
Inventor
Allan Scott Wagman
Heinz Ernst Moser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Achaogen Inc
Original Assignee
Achaogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achaogen Inc filed Critical Achaogen Inc
Publication of WO2010030811A2 publication Critical patent/WO2010030811A2/fr
Publication of WO2010030811A3 publication Critical patent/WO2010030811A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention concerne des antibiotiques de type b-lactame à base de carbacéphème ayant la structure (I), comprenant les stéréoisomères, sels pharmaceutiquement acceptables, esters et promédicaments de ceux-ci, dans laquelle Ar1, Ar2, R1 et R2 sont tels que définis ici. Les composés sont utiles dans le traitement d'infections bactériennes, en particulier celles causées par les espèces de Staphylococcus résistantes à la méthicilline.
PCT/US2009/056555 2008-09-10 2009-09-10 Antibiotiques de type β-lactame à base de carbacéphème Ceased WO2010030811A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9582008P 2008-09-10 2008-09-10
US61/095,820 2008-09-10
US17167509P 2009-04-22 2009-04-22
US61/171,675 2009-04-22

Publications (2)

Publication Number Publication Date
WO2010030811A2 WO2010030811A2 (fr) 2010-03-18
WO2010030811A3 true WO2010030811A3 (fr) 2010-08-12

Family

ID=41413340

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/056555 Ceased WO2010030811A2 (fr) 2008-09-10 2009-09-10 Antibiotiques de type β-lactame à base de carbacéphème

Country Status (1)

Country Link
WO (1) WO2010030811A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101835777A (zh) 2007-10-25 2010-09-15 尔察祯有限公司 碳头孢烯β-内酰胺抗生素
WO2010123997A1 (fr) * 2009-04-22 2010-10-28 Achaogen, Inc. Antibiotiques bêta-lactames carbacéphèmes
AU2015284307A1 (en) 2014-07-01 2017-02-02 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
CN109336810A (zh) * 2018-11-02 2019-02-15 浙江星月药物科技股份有限公司 一种卤代吡啶类氮氧化物的制备方法
CN117417293B (zh) * 2023-12-18 2024-03-19 齐鲁晟华制药有限公司 一种氟吡菌酰胺的合成方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362724A (en) * 1992-09-30 1994-11-08 Shionogi & Co., Ltd. Thioalkylthio carbacephalosporin derivatives
WO2004098500A2 (fr) * 2003-04-30 2004-11-18 Trine Pharmaceuticals, Inc. Beta-lactamine de la classe des carbacephems
US20080146535A1 (en) * 2003-04-30 2008-06-19 Tomasz Glinka Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors
WO2009055696A1 (fr) * 2007-10-25 2009-04-30 Achaogen, Inc. Antibiotiques bêta-lactames à carbacéphème

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362724A (en) * 1992-09-30 1994-11-08 Shionogi & Co., Ltd. Thioalkylthio carbacephalosporin derivatives
WO2004098500A2 (fr) * 2003-04-30 2004-11-18 Trine Pharmaceuticals, Inc. Beta-lactamine de la classe des carbacephems
US20050004095A1 (en) * 2003-04-30 2005-01-06 Glinka Tomasz W. Carbacephem beta-lactam antibiotics
US20080146535A1 (en) * 2003-04-30 2008-06-19 Tomasz Glinka Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors
WO2009055696A1 (fr) * 2007-10-25 2009-04-30 Achaogen, Inc. Antibiotiques bêta-lactames à carbacéphème

Also Published As

Publication number Publication date
WO2010030811A2 (fr) 2010-03-18

Similar Documents

Publication Publication Date Title
MX2010004407A (es) Antibioticos de carbacefem beta-lactama.
EP2662353A3 (fr) Agents antibactériens
EP2295402A3 (fr) Agents anti-bactériens
WO2008126034A3 (fr) Antibiotiques à base d'oxazolidinone
WO2008116813A3 (fr) Combinaison de médicaments pour le traitement d'infections bactériennes
WO2010108187A3 (fr) Composés et procédés pour traiter les infections microbiennes gastro-intestinales mammaliennes
WO2008039420A3 (fr) Nouveaux inhibiteurs de bêta-lactamase
WO2011044501A3 (fr) Analogues d'aminoglycoside antibactériens
WO2010030704A3 (fr) Analogues d’aminoglycosides antibactériens
CA2770066C (fr) Prostacycline, analogue ou derive de celui-ci pour le traitement de la fibrose kystique
WO2010132757A3 (fr) Analogues d'aminoglycoside antibactériens
WO2010030811A3 (fr) Antibiotiques de type β-lactame à base de carbacéphème
WO2014022382A3 (fr) Inhibiteurs de protéine kinase antibactérienne
WO2013083975A3 (fr) Nouveaux dérivés de pyrrole
WO2008071961A8 (fr) Dérivés de 2-quinolinone et de 2-quinoxalinone et leur utilisation en tant qu'agents antibactériens
WO2015024011A3 (fr) Composés antibactériens
WO2008014108A3 (fr) Promédicaments d'oxazolidinone antimicrobiens
WO2004098500A3 (fr) Beta-lactamine de la classe des carbacephems
NZ706734A (en) Pharmaceutical compositions useful for the treatment or control of bacterial infections
WO2009035553A3 (fr) Analogues de l'acide tétramique
WO2010036000A3 (fr) Nouveaux dérivés d'oxazolidinone avec une amidoxime cyclique ou une amidrazone cyclique et compositions pharmaceutiques les comprenant
WO2006063039A3 (fr) 3,6-bicyclolides
EP2495245A3 (fr) Substances antibactériennes de carbapenem gram-positives et leurs procédés de préparation
ATE480538T1 (de) 2-arylmethylazetidincarbapenemderivate und deren herstellung
WO2006065721A3 (fr) Bicyclolides de 11, 12-lactone

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09792432

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09792432

Country of ref document: EP

Kind code of ref document: A2